vs

Side-by-side financial comparison of LCI INDUSTRIES (LCII) and Surgery Partners, Inc. (SGRY). Click either name above to swap in a different company.

LCI INDUSTRIES is the larger business by last-quarter revenue ($932.7M vs $885.0M, roughly 1.1× Surgery Partners, Inc.). LCI INDUSTRIES runs the higher net margin — 2.0% vs -1.7%, a 3.7% gap on every dollar of revenue. On growth, LCI INDUSTRIES posted the faster year-over-year revenue change (16.1% vs 2.4%). Surgery Partners, Inc. produced more free cash flow last quarter ($90.6M vs $64.3M). Over the past eight quarters, Surgery Partners, Inc.'s revenue compounded faster (11.1% CAGR vs -1.8%).

Lucky Core Industries Limited, formerly known as ICI Pakistan, is a Pakistani conglomerate company headquartered in Karachi. It manufactures polyester, pharmaceutical, agrochemical, soda ash, and veterinary medicine.

United Surgical Partners International, Inc. (USPI) is an American ambulatory care company based in Dallas, Texas. It was founded by Don Steen in 1998.

LCII vs SGRY — Head-to-Head

Bigger by revenue
LCII
LCII
1.1× larger
LCII
$932.7M
$885.0M
SGRY
Growing faster (revenue YoY)
LCII
LCII
+13.7% gap
LCII
16.1%
2.4%
SGRY
Higher net margin
LCII
LCII
3.7% more per $
LCII
2.0%
-1.7%
SGRY
More free cash flow
SGRY
SGRY
$26.3M more FCF
SGRY
$90.6M
$64.3M
LCII
Faster 2-yr revenue CAGR
SGRY
SGRY
Annualised
SGRY
11.1%
-1.8%
LCII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LCII
LCII
SGRY
SGRY
Revenue
$932.7M
$885.0M
Net Profit
$18.7M
$-15.0M
Gross Margin
22.1%
Operating Margin
3.8%
12.5%
Net Margin
2.0%
-1.7%
Revenue YoY
16.1%
2.4%
Net Profit YoY
95.7%
86.2%
EPS (diluted)
$0.79
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LCII
LCII
SGRY
SGRY
Q4 25
$932.7M
$885.0M
Q3 25
$1.0B
$821.5M
Q2 25
$1.1B
$826.2M
Q1 25
$1.0B
$776.0M
Q4 24
$803.1M
$864.4M
Q3 24
$915.5M
$770.4M
Q2 24
$1.1B
$762.1M
Q1 24
$968.0M
$717.4M
Net Profit
LCII
LCII
SGRY
SGRY
Q4 25
$18.7M
$-15.0M
Q3 25
$62.5M
$-22.7M
Q2 25
$57.6M
$-2.5M
Q1 25
$49.4M
$-37.7M
Q4 24
$9.5M
$-108.5M
Q3 24
$35.6M
$-31.7M
Q2 24
$61.2M
$-15.5M
Q1 24
$36.5M
$-12.4M
Gross Margin
LCII
LCII
SGRY
SGRY
Q4 25
22.1%
Q3 25
24.4%
Q2 25
24.4%
Q1 25
24.1%
Q4 24
21.1%
Q3 24
24.0%
Q2 24
25.3%
Q1 24
23.1%
Operating Margin
LCII
LCII
SGRY
SGRY
Q4 25
3.8%
12.5%
Q3 25
7.3%
12.9%
Q2 25
7.9%
13.5%
Q1 25
7.8%
8.0%
Q4 24
2.0%
14.7%
Q3 24
5.9%
7.9%
Q2 24
8.6%
11.1%
Q1 24
6.0%
10.6%
Net Margin
LCII
LCII
SGRY
SGRY
Q4 25
2.0%
-1.7%
Q3 25
6.0%
-2.8%
Q2 25
5.2%
-0.3%
Q1 25
4.7%
-4.9%
Q4 24
1.2%
-12.6%
Q3 24
3.9%
-4.1%
Q2 24
5.8%
-2.0%
Q1 24
3.8%
-1.7%
EPS (diluted)
LCII
LCII
SGRY
SGRY
Q4 25
$0.79
$-0.11
Q3 25
$2.55
$-0.18
Q2 25
$2.29
$-0.02
Q1 25
$1.94
$-0.30
Q4 24
$0.37
$-0.86
Q3 24
$1.39
$-0.25
Q2 24
$2.40
$-0.12
Q1 24
$1.44
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LCII
LCII
SGRY
SGRY
Cash + ST InvestmentsLiquidity on hand
$222.6M
$239.9M
Total DebtLower is stronger
$945.2M
$3.6B
Stockholders' EquityBook value
$1.4B
$1.7B
Total Assets
$3.2B
$8.1B
Debt / EquityLower = less leverage
0.69×
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LCII
LCII
SGRY
SGRY
Q4 25
$222.6M
$239.9M
Q3 25
$199.7M
$203.4M
Q2 25
$191.9M
$250.1M
Q1 25
$231.2M
$229.3M
Q4 24
$165.8M
$269.5M
Q3 24
$161.2M
$221.8M
Q2 24
$130.4M
$213.5M
Q1 24
$22.6M
$185.2M
Total Debt
LCII
LCII
SGRY
SGRY
Q4 25
$945.2M
$3.6B
Q3 25
$947.8M
$3.5B
Q2 25
$948.0M
$3.5B
Q1 25
$938.3M
$3.4B
Q4 24
$757.3M
$3.3B
Q3 24
$822.5M
$3.1B
Q2 24
$829.7M
$3.0B
Q1 24
$855.3M
$2.8B
Stockholders' Equity
LCII
LCII
SGRY
SGRY
Q4 25
$1.4B
$1.7B
Q3 25
$1.4B
$1.7B
Q2 25
$1.4B
$1.7B
Q1 25
$1.4B
$1.7B
Q4 24
$1.4B
$1.8B
Q3 24
$1.4B
$1.9B
Q2 24
$1.4B
$2.0B
Q1 24
$1.4B
$2.0B
Total Assets
LCII
LCII
SGRY
SGRY
Q4 25
$3.2B
$8.1B
Q3 25
$3.2B
$7.9B
Q2 25
$3.2B
$8.0B
Q1 25
$3.1B
$7.9B
Q4 24
$2.9B
$7.9B
Q3 24
$3.0B
$7.5B
Q2 24
$3.0B
$7.5B
Q1 24
$3.0B
$7.0B
Debt / Equity
LCII
LCII
SGRY
SGRY
Q4 25
0.69×
2.10×
Q3 25
0.70×
2.00×
Q2 25
0.68×
1.98×
Q1 25
0.69×
1.98×
Q4 24
0.55×
1.83×
Q3 24
0.58×
1.63×
Q2 24
0.60×
1.56×
Q1 24
0.63×
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LCII
LCII
SGRY
SGRY
Operating Cash FlowLast quarter
$78.9M
$103.4M
Free Cash FlowOCF − Capex
$64.3M
$90.6M
FCF MarginFCF / Revenue
6.9%
10.2%
Capex IntensityCapex / Revenue
1.6%
1.4%
Cash ConversionOCF / Net Profit
4.22×
TTM Free Cash FlowTrailing 4 quarters
$278.3M
$195.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LCII
LCII
SGRY
SGRY
Q4 25
$78.9M
$103.4M
Q3 25
$97.2M
$83.6M
Q2 25
$112.2M
$81.3M
Q1 25
$42.7M
$6.0M
Q4 24
$106.6M
$111.4M
Q3 24
$78.4M
$65.2M
Q2 24
$192.9M
$82.8M
Q1 24
$-7.7M
$40.7M
Free Cash Flow
LCII
LCII
SGRY
SGRY
Q4 25
$64.3M
$90.6M
Q3 25
$80.9M
$63.8M
Q2 25
$99.5M
$57.9M
Q1 25
$33.7M
$-16.7M
Q4 24
$95.7M
$89.1M
Q3 24
$68.3M
$45.0M
Q2 24
$180.2M
$55.9M
Q1 24
$-16.3M
$19.7M
FCF Margin
LCII
LCII
SGRY
SGRY
Q4 25
6.9%
10.2%
Q3 25
7.8%
7.8%
Q2 25
9.0%
7.0%
Q1 25
3.2%
-2.2%
Q4 24
11.9%
10.3%
Q3 24
7.5%
5.8%
Q2 24
17.1%
7.3%
Q1 24
-1.7%
2.7%
Capex Intensity
LCII
LCII
SGRY
SGRY
Q4 25
1.6%
1.4%
Q3 25
1.6%
2.4%
Q2 25
1.2%
2.8%
Q1 25
0.9%
2.9%
Q4 24
1.4%
2.6%
Q3 24
1.1%
2.6%
Q2 24
1.2%
3.5%
Q1 24
0.9%
2.9%
Cash Conversion
LCII
LCII
SGRY
SGRY
Q4 25
4.22×
Q3 25
1.55×
Q2 25
1.95×
Q1 25
0.86×
Q4 24
11.17×
Q3 24
2.20×
Q2 24
3.15×
Q1 24
-0.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LCII
LCII

Travel Trailer And Fifth Wheels$378.4M41%
Chassis Chassis Partsand Slideout Mechanisms$206.1M22%
Furnitureand Mattresses$120.4M13%
Appliances$69.9M7%
Other Products$69.1M7%
Axlesand Suspension Solutions$62.3M7%
Motorhomes$34.2M4%

SGRY
SGRY

Private Insurance$460.5M52%
Government Revenue$368.6M42%
Other$19.8M2%
Self Pay Revenue$19.6M2%
Other Patient Service Revenue Sources$16.5M2%

Related Comparisons